Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

Signal-detection algorithms (SDAs) are recognized as vital tools in pharmacovigilance. However, their performance characteristics are generally unknown. By leveraging a unique gold standard recently made public by the Observational Medical Outcomes Partnership (OMOP) and by conducting a unique syste...

Celý popis

Podrobná bibliografie

Vydáno v:	Clinical pharmacology and therapeutics Ročník 93; číslo 6; s. 539
Hlavní autoři:	Harpaz, R, DuMouchel, W, LePendu, P, Bauer-Mehren, A, Ryan, P, Shah, N H
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.06.2013
Témata:	Adverse Drug Reaction Reporting Systems - statistics & numerical data Algorithms Humans Models, Statistical Pharmacovigilance United States United States Food and Drug Administration United States
ISSN:	1532-6535, 1532-6535
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!